Actusnews Wire - Professional broadcaster of corporate and regulated information, authorised by the AMF and the CSSF.

  NATUREX company press release from 05/07/2018

  05/07/2018 - 18:30

Half-Year summary of the liquidity contract


Half-Year summary of NATUREX's
liquidity contract with EXANE BNP PARIBAS

 

Press release
Avignon, July 5, 2018

 

Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of June 30, 2018, negotiation date:

  • 4,637 NATUREX shares
  • 634,164.00 euros

It is reminded that the following assets appeared on the liquidity account as of December 31, 2017, negotiation date:

  • 4,899 NATUREX shares
  • 604,069.00 euros

 

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com

 

About Naturex

Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.

The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.

Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group employs 1,700 people worldwide and in 2017 had revenue of €404.9 million.

The Group is listed on Euronext Paris, Compartment B - Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY
 NATUREX, From Nature to You

 

  • Contact investors / financial media

Carole Alexandre
Head of Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com